Is Diamond Biotechnology Co stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Diamond Biotechnology Co pays dividends. Last time was Monday 2nd of September 2024 where the investors holding the stock on Monday 5th of August 2024 were paid TWD0.1848 per share. Over the last 4 times between 2021 and 2024, Diamond Biotechnology Co has paid TWD0.501338 with an average of TWD0.13 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Diamond Biotechnology Co 10 years ago, but if you had invested on Friday 29th of January 2021 when the price was TWD52.79, you would have made a profit of TWD19.71 per share or 37.34%
Yes, the average daily trading liquidity for Diamond Biotechnology Co is TWD74 876 thousand. You should therefore be able to get in and out of your positions relatively fast.
Diamond Biotechnology Co has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. Diamond Biotechnology Co has a good net profit margin of 9.46% and should have high tolerances against inflation.
We have calculated the inflation risk for Diamond Biotechnology Co to be medium [0.55 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.